Integer Holdings Co. (NASDAQ:ITGR) was up 1.2% during mid-day trading on Wednesday . The stock traded as high as $23.56 and last traded at $23.28, with a volume of 312,324 shares. The stock had previously closed at $23.00.

Several equities research analysts recently issued reports on ITGR shares. TheStreet downgraded Integer Holdings from a “hold” rating to a “sell” rating in a research note on Friday, July 1st. Zacks Investment Research raised Integer Holdings from a “sell” rating to a “hold” rating in a research note on Thursday, May 19th. Finally, Sterne Agee CRT reissued a “buy” rating on shares of Integer Holdings in a research note on Monday, May 16th. Two analysts have rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $57.00.

The firm has a 50-day moving average of $0.00 and a 200 day moving average of $0.00. The stock’s market cap is $719.51 million.

Integer Holdings (NASDAQ:ITGR) last released its earnings results on Thursday, July 28th. The company reported $0.56 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.70 by $0.14. The firm earned $348.38 million during the quarter, compared to the consensus estimate of $356.72 million. During the same period in the prior year, the business earned $0.73 earnings per share. The business’s revenue for the quarter was up 99.2% on a year-over-year basis. On average, equities research analysts anticipate that Integer Holdings Co. will post $2.64 earnings per share for the current year.

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.